Anti-CD20 Monoclonal Antibodies Market Emerging Trends and Top Key Vendors to Watch - Biogen, Genentech, Genmab A/S, Immunomedics, and Novartis AG in 2025
The market for anti-CD20 monoclonal antibodies is primarily driven by increasing research and development activities in generating potent anti-CD20 monoclonal antibodies. Various research funding and grants, and investment are done by both private and government bodies to support R&D activities and are driving the growth of anti-CD20 monoclonal antibodies market. In addition, rising demand for personalized medicine coupled with increasing use of immunotherapy, and potential benefits from the treatment in terms of fewer side effects, low cost of production are...
View full press release